Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Net Cash Flow (2016 - 2025)

Healthy Extracts' Net Cash Flow history spans 11 years, with the latest figure at -$42517.0 for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 465.96% year-over-year to -$42517.0; the TTM value through Dec 2025 reached $34915.0, down 62.29%, while the annual FY2025 figure was $34915.0, 62.29% down from the prior year.
  • Net Cash Flow reached -$42517.0 in Q4 2025 per HYEX's latest filing, down from -$11042.0 in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $173731.0 in Q1 2021 to a low of -$171800.0 in Q3 2021.
  • Average Net Cash Flow over 5 years is $4386.7, with a median of -$727.5 recorded in 2022.
  • Peak YoY movement for Net Cash Flow: soared 364.08% in 2021, then plummeted 465.96% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at $106960.0 in 2021, then crashed by 107.7% to -$8233.0 in 2022, then crashed by 227.34% to -$26950.0 in 2023, then soared by 143.11% to $11618.0 in 2024, then tumbled by 465.96% to -$42517.0 in 2025.
  • Per Business Quant, the three most recent readings for HYEX's Net Cash Flow are -$42517.0 (Q4 2025), -$11042.0 (Q3 2025), and $81696.0 (Q2 2025).